Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 6, 2019Biology of Blood and Marrow TransplantationOpen Access

Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

BJBarbara H. JohnsonJohnson & Johnson (United States)ATAliki TaylorGilead Sciences (United Kingdom)GKGilwan KimEli Lilly (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Johnson et al. (2019) studied this question.

synapsesocial.com/papers/6a21cebe7cd64f3298c00ed5https://doi.org/10.1016/j.bbmt.2018.12.839
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment Costs and Survival in Patients with Grades III-IV Acute Graft-Versus-Host Disease after Allogenic Hematopoietic Stem Cell Transplantation During Three Decades2006 · 21 citations
  2. 2The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation2000 · 717 citations
  3. 3Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy1990 · 144 citations